Evidence map›Paper›PMID 22798222›Full record

ArticleNeuromolecular medicine2012

Lipidomic profiling of phosphocholine-containing brain lipids in mice with sensorimotor deficits and anxiety-like features after exposure to Gulf War agents.

Laila Abdullah, James E Evans, Alex Bishop, Jon M Reed, Gogce Crynen, John Phillips, Robert Pelot, Myles A Mullan, Austin Ferro, Christopher M Mullan and 3 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Neuromolecular medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05252949 (A Randomized, Double-blind, Placebo-controlled Clinical Trial of Oleoylethanolamide), which is not on this map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05252949 nacompletednot on this mapstarted 2021, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled Clinical Trial of Oleoylethanolamide (OEA) for Targeting Lipid Metabolism in Gulf War Illness

TypeinterventionalSponsorRoskamp Institute Inc.Ran2021 to 2025Enrolled52ConditionsGulf War IllnessArmsOleoylethanolamide (OEA), Placebo
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. FDA-approved cannabidiol [EpidiolexMilitary Medical Research · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Laila AbdullahRoskamp Institute, Sarasota, FL 34243, USA. labdullah@rfdn.org
James E Evans
Alex Bishop
Jon M Reed
Gogce Crynen
John Phillips
Robert Pelot
Myles A Mullan
Austin Ferro
Christopher M Mullan
Michael J Mullan
Ghania Ait-Ghezala
Fiona C Crawford
Roskamp Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The central nervous system (CNS)-based symptoms of Gulf War Illness (GWI) include motor dysfunction, anxiety, and cognitive impairment. Gulf War (GW) agents, such as pyridostigmine bromide (PB), permethrin (PER), N,N-diethyl-meta-toluamide (DEET), and stress, are among the contributory factors to the pathobiology of GWI. This study characterizes disturbances in phosphocholine-containing lipids that accompany neurobehavioral and neuropathological features associated with GW agent exposure. Exposed mice received PB orally, dermal application of PER and DEET and restraint stress daily for 28 days, while controls received vehicle during this period. Neurobehavioral studies included the rotarod, open field, and Morris water maze tests. Histopathological assessments included glial fibrillary acid protein, CD45, and Nissl staining. Liquid chromatography/mass spectrometry with source collision-induced dissociation in negative and positive ionization scanning modes was performed to characterize brain phosphatidylcholine (PC) and sphingomyelin (SM). A significant increase in ether containing PC (ePC34:0, ePC36:2, and ePC36:1) or long-chain fatty acid-containing PC (38:1, 40:4, 40:2) was observed in exposed mice compared with controls. Among differentially expressed PCs, levels of those with monounsaturated fatty acids were more affected than those with saturated and polyunsaturated fatty acids. Sensorimotor deficits and anxiety, together with an increase in astrocytosis, were observed in exposed mice compared with controls. These lipid changes suggest that alterations in peroxisomal pathways and stearoyl-CoA desaturase activity accompany neurobehavioral and neuropathological changes after GW agent exposure and represent possible treatment targets for the CNS symptoms of GWI.

Indexed as

Disease Models, AnimalAnimalsAnxietyAtaxiaBrain ChemistryCerebral CortexDEETDentate GyrusExploratory BehaviorFatty AcidsFemaleGliosisMaleMaze LearningMiceMice, Inbred C57BLDEETFatty AcidsNerve Tissue ProteinsPermethrinPhosphatidylcholinesPyridostigmine BromideSphingomyelinsStearoyl-CoA Desaturase

Identifiers

PMID22798222
OpenAlexW1977103483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.